McGaughy R Kent Jr

CIK 00014028565 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001402856

Recent Transactions

50 trades

Award
Instil Bio, Inc.$TIL
Stock Option (Right to Buy)
2025-05-28+6,500→ 6,500 total
Award
Instil Bio, Inc.$TIL
Stock Option (Right to Buy)
2024-06-13+5,000→ 5,000 total
Other
PROCEPT BioRobotics Corp$PRCT
Common Stock
2024-05-03−1,785,127→ 2,823,681 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−4,275→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−4,591→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−699→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−399→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−2,896,901→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−9,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−11,240→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class B common stock
2023-09-26−1,692,857→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class B common stock
2023-09-26−3,109→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−2,773→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)/
2023-09-26−6,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−25,004→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class B common stock
2023-09-26−51,095→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−4,787→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class B common stock
2023-09-26−278,309→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−6,300→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−280→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−6,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−5,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−1,628→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−892→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−690→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−8,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−3,185→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-09-26−1,844→ 0 total
Award
Instil Bio, Inc.$TIL
Stock Option (Right to Buy)
2023-06-14+1,500→ 1,500 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-06-07+4,275→ 4,275 total
Award
REATA PHARMACEUTICALS INC
Stock Option (right to buy)
2023-06-07$73.68/sh+1,628→ 1,628 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−400,675→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−675,181→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2023-04-04−38,667→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−63,671→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−1,310,701→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−3,687,781→ 0 total
Disposition to Issuer
Apollo Endosurgery, Inc.
Common Stock
2023-04-04−45,594→ 0 total
Gift
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-03−33,217→ 0 total
Conversion
Apollo Endosurgery, Inc.
6.0% Convertible Debentures due 2026
2022-12-28→ 0 total
Conversion
Apollo Endosurgery, Inc.
6.0% Convertible Debentures due 2026
2022-12-28→ 0 total
Conversion
Apollo Endosurgery, Inc.
Class A common stock
2022-12-28$3.25/sh+586,308→ 1,310,701 total
Conversion
Apollo Endosurgery, Inc.
Class A common stock
2022-12-28$3.25/sh+1,465,770→ 3,687,781 total
Conversion
Apollo Endosurgery, Inc.
Class A common stock
2022-12-28$3.25/sh+146,577→ 675,181 total
Conversion
Apollo Endosurgery, Inc.
6.0% Convertible Debentures due 2026
2022-12-28→ 0 total
Other
PROCEPT BioRobotics Corp$PRCT
Common Stock
2022-12-05−1,726,534→ 5,029,869 total
Other
PROCEPT BioRobotics Corp$PRCT
Common Stock
2022-11-14−1,729,482→ 6,993,137 total
Other
PROCEPT BioRobotics Corp$PRCT
Common Stock
2022-09-09−986,640→ 8,955,675 total
Other
PROCEPT BioRobotics Corp$PRCT
Common Stock
2022-09-06−743,021→ 10,075,491 total
Award
Apollo Endosurgery, Inc.
Stock Option (Right to Buy)
2022-06-14+38,667→ 38,667 total

Companies

Recent Filings

Address

C/O INSTIL BIO, INC. 3963 MAPLE AVENUE, SUITE 350

DALLAS, TX, 75219

View on SEC.gov